TEVA PHARMACEUTICALS IRELAND

TRADING NAME IVAX INTERNATIONAL BV UNIT 301 WATERFORD INDUSTRIAL EST. WATERFORD IE

Summary Information

There are a total of 1,246 bills of lading on file for TEVA Pharmaceuticals Ireland between March 6th, 2019 and January 22nd, 2025.

Of those 1,246 bills of lading, 8 were within the past 30 days and 39 were within the past 90 days.

Total Records1,246
Shipper Records1,246
Consignee Records0
Notify Party Records0
First Shipment on FileMar 6th, 2019
Most Recent Shipment on FileJan 22nd, 2025
Records in Last 30 Days8
Records in Last 90 Days39
Records in the Past Year233

Bills of Lading by Month for TEVA Pharmaceuticals Ireland

Register Now for Comprehensive Access

Subscribe now for unlimited access to all manifests, vessels, shippers, consignees, and more for TEVA PHARMACEUTICALS IRELAND.

Sankey Diagram of Associated Companies

Below is a Sankey Diagram of the top 5 companies associated with TEVA Pharmaceuticals Ireland, and the top 4 companies associated with those associations.

Associated Companies

Below are the top 5 companies associated with TEVA Pharmaceuticals Ireland in terms of total bills of lading. Total Records are based on data obtained since March 1st, 2019.

Company Name Recent Shipment Total Records Associations
TEVA PHARMACEUTICAL USA INCJan 20257,0581,199
TEVA CANADA CORPORATEJan 20257439
JABIL HEALTHCAREJan 20253205
TEVA CANADA LIMITEDSep 2024582
Jan 202511

Other Companies Listed Alphabetically

Below are other companies when arranged alphabetically. There is not neccessarily any association to TEVA Pharmaceuticals Ireland.

25 Most Recent Bills of Lading

Run Date Master BOL House BOL Voyage # Bill Type Carrier Code IMO # Vessel Name Arrival Date US Port Foreign Port Quantity Weight Type of Service Shipper Consignee Notify Party Commodity
2025-01-29IILU142415800BANQ1064218645983WHouse BillBANQINDEPENDENT HORIZON2025-01-28CHESTER, PENNSYLVANIACOBH IRELAND1,446 CTN9,878 KTEVA PHARMACEUTICALS IRELAND (IVAXTEVA PHARMACEUTICAL USA INCTEVA PHARMACEUTICALS USAALBUTEROL SULFATE MDI INH 0.09MG INH 1 1446 CTNS ON 37 PLT NET WEIGHT: 8745.408 KGS TEMPERATURE SETTING: +22 .
2025-01-29IILU141994500BANQ1063927846983WHouse BillBANQINDEPENDENT HORIZON2025-01-28CHESTER, PENNSYLVANIACOBH IRELAND777 CTN3,273 KTEVA PHARMACEUTICALS IRELAND (IVAXTEVA PHARMACEUTICAL USA INCTEVA PHARMACEUTICALS USAFLUTICASONE SALMETEROL 0.25 0.05MG PWD60 777 CTNS ON 17 PLT NET WEIGHT: 3272.376 KGS TEMPERATURE SETTING: +22
2025-01-23IILU142035600BANQ1063928030982WHouse BillBANQ9246712INDEPENDENT FUTURE2025-01-22CHESTER, PENNSYLVANIACOBH IRELAND742 CAS4,314 KTEVA PHARMACEUTICALS IRELAND (IVAXTEVA CANADA CORPORATETEVA CANADA CORPORATETEVA-SALBUTAMOL 100 MCG HFA INH 200 DOSE 742 CTNS ON 19 PLT NET WEIGHT: 4313.48KGS TEMPERATURE SETTING: +22
2025-01-23IILU141994400BANQ1063927421982WHouse BillBANQ9246712INDEPENDENT FUTURE2025-01-22CHESTER, PENNSYLVANIACOBH IRELAND1,600 CTN10,901 KTEVA PHARMACEUTICALS IRELAND (IVAXTEVA PHARMACEUTICAL USA INCTEVA PHARMACEUTICALS USAALBUTEROL SULFATE MDI INH 0.09MG INH 1 1600 CTNS ON 40 PLT NET WEIGHT: 9676.8 KGS TEMPERATURE SETTING: +22

Sample Bill of Lading

Relevant Dates

Run Date2025-01-29
Estimated Arrival Date2025-01-28
Actual Arrival Date2025-01-28
Trade Update Date2025-01-16

Bill of Lading Overview

Master BOL #IILU142417300
House BOL #BANQ1064218973
Manifest Number000001
Bill TypeHouse Bill
Carrier CodeBANQ
Voyage #983W
IMO #
Vessel NameINDEPENDENT HORIZON
Vessel CountryPT
Place of ReceiptWATERFORD
Foreign Port of LadingCOBH IRELAND (41905)
Port of UnladingCHESTER, PENNSYLVANIA (1102)
Port of Destination
Foreign Port of Destination
Weight10901 K
Weight in KG10,901 KG
Quantity1600 CTN
Volume X
Record StatusNew Record
In-bond Entry Type
Transportation ModeVessel, containerized
Container OTPU6208733
Commodity Description ALBUTEROL SULFATE MDI INH 0.09MG INH 1 1600 CTNS ON 40 PLT NET WEIGHT: 9676.800 KGS TEMPERATURE SETTING: +22

Shipper

Shipper NameTEVA PHARMACEUTICALS IRELAND (IVAX
Address Line 1INTERNATIONAL BV)
Address Line 2WATERFORD INDUSTRIAL EST. UNIT 301
Address Line 3WATERFORD IE

Consignee

Consignee NameTEVA PHARMACEUTICAL USA INC
Address Line 1111 NEW BRITAIN BLVD
Address Line 2CHALFONT PA 18914-183 US

Notify Party

Notify Party NameTEVA PHARMACEUTICALS USA
Address Line 11090 HORSHAM RD
Address Line 2NORTH WALES PA 19040 US

#1 -- Container OTPU6208733

Container NumberOTPU6208733
Seal Number 1BB000404
Seal Number 1BB000404
Equipment Description CodeCZ
Equipment DescriptionRefrigerated Container
Container Length40ft 0in (04000)
Container Height0ft 0in (00000000)
Container Width0ft 0in (00000000)
Container Type
Load StatusLoaded
Type of Service
Cargo Description 1ALBUTEROL SULFATE MDI INH 0.09MG INH 1 1600 CTNS ON 40 PLT NET WEIGHT: 9676.800 KGS TEMPERATURE SETTING: +22
Marks and Numbers 1INVOICE NO: 9367004451 PO: 4500285169 SELLERS REF STCC00069948 NO MARKS

Map of Activity by Port

TEVA PHARMACEUTICALS IRELAND Top US Ports

Port of Unlading Total Records Recent Shipment
Chester, Pennsylvania8462025-01-23
Philadelphia, Pennsylvania3842022-12-29
Boston, Massachusetts142023-06-15
New York, New York12025-01-17
Newark, New Jersey12021-08-27

TEVA PHARMACEUTICALS IRELAND Top Foreign Ports

Port of Lading Total Records Recent Shipment
Cobh Ireland8592025-01-23
Antwerp Belgium3712022-07-15
Rotterdam Netherlands62020-11-11
Dublin Ireland52025-01-17
Le Havre France32022-09-10
Bremerhaven Germany22020-07-16

TEVA PHARMACEUTICALS IRELAND Address and Name Permutations

Below are the top 4 company names and addresses for TEVA Pharmaceuticals Ireland that were combined to create this record. While we try to make sure everything is as accurate as possible we can't guarantee complete accuracy for all records so please notify us of any errors.

Company Name Address Last Record Records
TEVA PHARMACEUTICALS IRELANDTRADING NAME IVAX INTERNATIONAL BV UNIT 301 WATERFORD INDUSTRIAL EST. WATERFORD IE2022-11-09673
TEVA PHARMACEUTICALS IRELAND (IVAXINTERNATIONAL BV) WATERFORD INDUSTRIAL EST. UNIT 301 WATERFORD IE2025-01-23571
TEVA PHARMACEUTICALS IRELAND2022-07-071
TEVA PHARMACEUTICALS IRELAND2022-07-071